Cargando…
(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
BACKGROUND: Ovarian cancer is a serious threat for women health and the early diagnosis of this cancer might improves the survival rate of patients. The use of the targeted radiopharmaceuticals could be a non-invasive and logical method for tumor imaging. The aim of this study was to radiolabel GE11...
Autores principales: | Rahmanian, Najmeh, Hosseinimehr, Seyed Jalal, Khalaj, Ali, Noaparast, Zohreh, Abedi, Seyed Mohammad, Sabzevari, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414288/ https://www.ncbi.nlm.nih.gov/pubmed/28464952 http://dx.doi.org/10.1186/s40199-017-0179-8 |
Ejemplares similares
-
(99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging
por: Ahmadpour, Sajjad, et al.
Publicado: (2018) -
(99m)Tc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice
por: Sadeghi, Hossein, et al.
Publicado: (2018) -
The paradox role of caspase cascade in ionizing radiation therapy
por: Rahmanian, Najmeh, et al.
Publicado: (2016) -
Technetium-99m chelator-free radiolabeling of specific glutamine tumor imaging nanoprobe: in vitro and in vivo evaluations
por: Ghoreishi, Seyedeh Masoumeh, et al.
Publicado: (2018) -
The Radiolabeled HER3 Targeting Molecules for Tumor Imaging
por: Molavipordanjani, Sajjad, et al.
Publicado: (2021)